Novo Nordisk says Ozempic helped patients with Type 2 diabetes in one new way
Novo Nordisk A.S. said Tuesday a five-year trial of its Ozempic weight-loss drug helped reduce the risk of kidney disease-related ...
Read moreNovo Nordisk A.S. said Tuesday a five-year trial of its Ozempic weight-loss drug helped reduce the risk of kidney disease-related ...
Read moreBetter Therapeutics Inc. shares surged in the extended session Monday after the digital therapeutics company got Food and Drug Administration ...
Read moreEli Lilly & Co. said Thursday it has agreed to acquire Sigilon Therapeutics Inc. in a deal worth up to ...
Read moreEli Lilly’s announcement that it will cut the price of insulin for people with commercial health insurance — capping out-of-pocket ...
Read moreTodayheadline the independent news and topics discovery
A home-grown and independent news and topic aggregation . displays breaking news linking to news websites all around the world.
© 2024 All rights are reserved Today Headline